USPTO 2015–2025 USPTO PatentsView US Corporation

Boehringer Ingelheim Animal Health USA Inc.

USPTO PatentsView assignee record - 85 granted patents across 48 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

16.4

Avg claims per patent

+247%

5-year filing velocity

The verdict

Boehringer holds 85 US patents across 48 technology areas, rank #4,184 of 50,000 tracked assignees.

#4,184
of 50,000 US assignees by volume: Top 10%
by Innovation Score (52.8/100): 16.4
avg claims per patent: +247%
filing velocity, last 5 yrs

Portfolio overview

Boehringer Ingelheim Animal Health USA Inc. has been granted 85 US utility patents between 2019 and 2025, placing Boehringer Ingelheim Animal Health USA Inc. at rank #4,184 across all assignees tracked by PlainPatent. This portfolio spans 48 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.4 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Boehringer Ingelheim Animal Health USA Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Boehringer sits between Arthrocare Corporation (85 patents, rank #4,180) and Construction Research & Technology Gmbh (85 patents, rank #4,188) - the closest US assignees by grant volume. The composite Innovation Score of 52.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 66 grants, compared with 19 in the 2015–2019 window, a +247% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Boehringer Ingelheim Animal Health USA Inc.'s 16.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 48 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Boehringer Ingelheim Animal Health USA Inc. against peers pursuing similar technology classes.

Arthrocare

85
Avalara

85
Beijing Jingdong…

85
Biomarin Pharmace…

85
Bitdefender IPR M…

85
Changzhou Univers…

85
Chemetall

85
Construction Rese…

85
Boehringer Ingelh… ◀

85

What this shows Boehringer holds 85 patents at rank #4,184, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Boehringer

By rank, the assignees closest to #4,184 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Boehringer's primary technology class.

Boehringer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

53 Top 10% higher than 90% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Boehringer Ingelheim Animal Health USA Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	19	22.4%
2020	29	34.1%
2021	8	9.4%
2022	10	11.8%
2023	8	9.4%
2024	8	9.4%
2025	3	3.5%

Which technologies does Boehringer Ingelheim Animal Health USA Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 57

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 56

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 29

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 27

C07K - PEPTIDES 24

C07D - HETEROCYCLIC COMPOUNDS 21

A01K - ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS 10

A61D - VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS 9

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 8

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 7

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 7

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 5

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 4

A01P - BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS 4

B05B - SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES 3

Top 15 of 48 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#4,184

Across all tracked assignees

Innovation Score

52.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Boehringer Ingelheim Animal Health USA Inc. hold?

Boehringer Ingelheim Animal Health USA Inc. holds 85 US granted patents filed between 2019 and 2025, spanning 48 technology areas.

What is Boehringer Ingelheim Animal Health USA Inc.'s Innovation Score?

Boehringer Ingelheim Animal Health USA Inc. has an Innovation Score of 52.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Boehringer Ingelheim Animal Health USA Inc. focus on?

Boehringer Ingelheim Animal Health USA Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 57 patents. The company has filed patents in 48 CPC subclasses total.

Is Boehringer Ingelheim Animal Health USA Inc.'s patent filing rate increasing or decreasing?

Boehringer Ingelheim Animal Health USA Inc.'s recent filing velocity is +247% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Boehringer Ingelheim Animal Health USA Inc.'s patents?

Boehringer Ingelheim Animal Health USA Inc.'s patents average 16.4 claims each. This falls within the standard range, providing solid legal coverage.

How is the Boehringer Ingelheim Animal Health USA Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Boehringer's 85 grants land it in the top 10% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Boehringer ranks #4,184 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.